Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Follow-up confirms safety of PN-27.1

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

DAG analogues as potent PKC agonists available for licensing

Oct. 25, 1996

Hybridon anti-VEGF antisense compounds for neovascularization disorders

Oct. 25, 1996

NIH offers peptides with OMT residues as potential therapeutic agents

Oct. 25, 1996

Novel APC-based method for producing cancer therapeutics and vaccines available for licensing

Oct. 25, 1996

Human chorionic gonadotropin use in Kaposi's sarcoma described: NIH seeks licensees

Oct. 25, 1996

INSERM claims antitumor antibody

Oct. 25, 1996

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.